Immune Checkpoint Inhibitors + Chemotherapy Versus Chemotherapy in the Neoadjuvant Treatment of Locally Advanced Colorectal Cancer

NCT06154538 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

170

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Colorectal Carcinoma

Interventions

DRUG: Immune checkpoint inhibitor
DRUG: FOLFOX regimen

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences